Lilly Ventures

Lilly Ventures is the corporate venture capital arm of Eli Lilly and Company, focusing on investments in early to expansion-stage life sciences companies. The firm aims to support the success of these companies through strategic investments and value-adding resources. Lilly Ventures currently manages approximately $200 million in assets and concentrates on three major areas of interest: biotechnology, medical devices, and diagnostics.

The firm's investment strategy encompasses a broad range of stages, including seed, early stage, Series A, Series B, growth, late stage, pre-IPO, buyout, turnaround, and distressed investments. Geographically, Lilly Ventures focuses on the United States and Europe, seeking opportunities that align with its expertise in the life sciences sector. The industries of interest include biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, digital health, medical research, healthcare IT, medical equipment, healthcare technology, healthcare analytics, healthcare consulting, healthcare distribution, healthcare manufacturing, and healthcare retail.

Lilly Ventures is headquartered in Indianapolis, Indiana, and operates as a subsidiary of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. The firm is committed to advancing healthcare by supporting innovative companies that aim to improve patient outcomes and quality of life. Through its investments, Lilly Ventures seeks to foster growth and innovation within the life sciences industry, leveraging the resources and expertise of its parent company to drive success for its portfolio companies.